Related references
Note: Only part of the references are listed.B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells
Qiang Wu et al.
BMC CANCER (2014)
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
T. Sato et al.
ONCOGENE (2014)
Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease
Aaron J. Knox et al.
BREAST CANCER RESEARCH (2014)
The influence of glucocorticoid signaling on tumor progression
Paul A. Volden et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Global profiling of prolactin-modulated transcripts in breast cancer in vivo
Takahiro Sato et al.
MOLECULAR CANCER (2013)
Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
D. M. Cittelly et al.
ONCOGENE (2013)
Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties
Sunshine Daddario Axlund et al.
HORMONES & CANCER (2013)
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
Ning Yang et al.
BREAST CANCER RESEARCH (2013)
Genome-Wide Progesterone Receptor Binding: Cell Type-Specific and Shared Mechanisms in T47D Breast Cancer Cells and Primary Leiomyoma Cells
Ping Yin et al.
PLOS ONE (2012)
Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch
James M. Haughian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
Amy R. Peck et al.
BREAST CANCER RESEARCH (2012)
A High-Content Assay to Identify Small-Molecule Modulators of a Cancer Stem Cell Population in Luminal Breast Cancer
Byong Hoon Yoo et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The role of BCL6 in lymphomas and routes to therapy
Simon D. Wagner et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Biobehavioral Influences on Cancer Progression
Erin S. Costanzo et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2011)
Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure
Amy R. Peck et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition
Cihangir Duy et al.
NATURE (2011)
PTP1B Suppresses Prolactin Activation of Stat5 in Breast Cancer Cells
Kevin J. Johnson et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Prolactin Inhibits BCL6 Expression in Breast Cancer through a Stat5a-Dependent Mechanism
Thai H. Tran et al.
CANCER RESEARCH (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast Cells
Alexandr Plotnikov et al.
CANCER RESEARCH (2009)
Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition
Ahmed S. Sultan et al.
CANCER SCIENCE (2008)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts
Kathryn B. Horwitzt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Do stress-related psychosocial factors contribute to cancer incidence and survival?
Yoichi Chida et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Stress history and breast cancer recurrence
Oxana Palesh et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2007)
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of akt and stat5a/b pathways
Lynn M. Neilson et al.
MOLECULAR ENDOCRINOLOGY (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors
Chengwen Zhang et al.
CANCER BIOLOGY & THERAPY (2007)
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression
E. A. Rakha et al.
HISTOPATHOLOGY (2007)
STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas
S. R. Walker et al.
ONCOGENE (2007)
P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ
Joana Paredes et al.
VIRCHOWS ARCHIV (2007)
Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer
H. Yamashita et al.
ENDOCRINE-RELATED CANCER (2006)
Unbiased recursive partitioning: A conditional inference framework
Torsten Hothorn et al.
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2006)
Dexamethasone decreases xenograft response to paclitaxel through inhibition of tumor cell apoptosis
Diana Pang et al.
CANCER BIOLOGY & THERAPY (2006)
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells
Z Nouhi et al.
CANCER RESEARCH (2006)
Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.
CA Sartorius et al.
CANCER RESEARCH (2005)
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells
AS Sultan et al.
ONCOGENE (2005)
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells
W Wu et al.
CANCER RESEARCH (2004)
Signal transducer and activator of transcription-5 activation and breast cancer prognosis
MT Nevalainen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation
S Logarajah et al.
ONCOGENE (2003)
Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification
XT Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database
WF Anderson et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
AL Shaffer et al.
IMMUNITY (2000)
Share Paper
